PlumX Metrics
Embed PlumX Metrics

7-Methoxytacrine and 2-Aminobenzothiazole Heterodimers: Structure-Mechanism Relationship of Amyloid Inhibitors Based on Rational Design

ACS Chemical Neuroscience, ISSN: 1948-7193, Vol: 11, Issue: 5, Page: 715-729
2020
  • 12
    Citations
  • 0
    Usage
  • 22
    Captures
  • 1
    Mentions
  • 0
    Social Media
Metric Options:   Counts1 Year3 Year

Metrics Details

Most Recent News

7-MEOTA and 2-aminobenzothiazole heterodimers: structure-mechanism relationship of amyloid inhibitors based on rational design.

ACS Chem Neurosci. 2020 Feb 3; Authors: Gancar M, Ho K, Mohid SA, Thai NQ, Bednarikova Z, Nguyen HL, Bhunia A, Nepovimova E, Li MS, Gazova Z PubMed: 32011847 Submit Comment

Article Description

The formation and accumulation of amyloid aggregates are the phenomena that accompany amyloidoses, which are currently untreatable and include Alzheimer's and Parkinson's diseases, diabetes mellitus, non-neuropathic lysozyme systemic amyloidosis, and others. One of the very promising therapeutic approaches seems to be an inhibition of amyloid formation and/or clearance of amyloid aggregates. Small molecules have a great potential to interfere with amyloid fibrillation of peptides and polypeptides, which can be improved by connection of cyclic structures into single multicyclic molecules and their dimerization. In our study, we focused on heterodimers consisting of 7-methoxytacrine (7-MEOTA) and 2-aminobenzothiazole (BTZ) parent molecules connected by an aliphatic linker. Using in vitro and in silico methods, we investigated the ability of studied compounds to inhibit the amyloid aggregation of hen egg white lysozyme. Heterodimerization led to significant improvement of inhibitory activity compared to that of the parent molecules. The efficiency of the heterodimers varied; the most effective inhibitor contained the longest linker, eight carbons long. We suggest that binding of a heterodimer to a lysozyme blocks the interaction between the β-domain and C-helix region essential for the formation of amyloid cross-β structure. Elongation of the linker ultimately enhances the compound's ability to prevent this interaction by allowing the BTZ part of the heterodimer to bind more effectively, increasing the compound's binding affinity, and also by greater steric obstruction. This study represents an important contribution to the recent rational design of potential lead small molecules with anti-amyloid properties, and the heterodimers studied are prospective candidates for the treatment of systemic lysozyme amyloidosis and other amyloid-related diseases.

Bibliographic Details

Gancar, Miroslav; Ho, Kiet; Mohid, Sk Abdul; Thai, Nguyen Quoc; Bednarikova, Zuzana; Nguyen, H Linh; Bhunia, Anirban; Nepovimova, Eugenie; Li, Mai Suan; Gazova, Zuzana

American Chemical Society (ACS)

Biochemistry, Genetics and Molecular Biology; Neuroscience

Provide Feedback

Have ideas for a new metric? Would you like to see something else here?Let us know